SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-12-000034
Filing Date
2012-05-30
Accepted
2012-05-30 16:51:58
Documents
1
Period of Report
2012-05-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4783
  Complete submission text file 0000885590-12-000034.txt   6391
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LAURE CROWN VENTURE 1620 26TH ST SOUTH TOWER SUITE 300 SANTA MONICA CA 90404
Business Address
PAUL LAURENCE E (Reporting) CIK: 0001190966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 12878217